Dr. Williamson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1100 Reid Pkwy
Richmond, IN 47374Phone+1 765-935-8773Fax+1 765-935-8774
Education & Training
SSM Health/Saint Louis University School of MedicineFellowship, Hematology and Medical Oncology, 2004 - 2007
Indiana University School of Medicine/Ball MemorialResidency, Internal Medicine, 2001 - 2004
Michigan State University College of Osteopathic MedicineClass of 2001
Certifications & Licensure
IN State License 2002 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
- Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic Start of enrollment: 2014 Mar 29
Publications & Presentations
PubMed
- 86 citationsA phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier cancer ...Greg Andrew Durm, Salma K. Jabbour, Sandra Althouse, Ziyue Liu, Ahad Ali Sadiq
Cancer. 2020-10-01 - 41 citationsEmergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patientsSai-Hong Ignatius Ou, Leora Horn, Marcelo Rocha Cruz, Davood Vafai, Christine M. Lovly
Lung Cancer. 2017-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
